Myhep Dvir Tablet belongs to a class of drugs called antivirals. It is used to treat chronic HCV (Hepatitis C virus) infection. Hepatitis C is a viral infection that causes inflammation or swelling in the liver, which can lead to severe liver damage. It is caused by the hepatitis C virus (HCV) and spreads through contact when infected blood enters the bloodstream of someone who is not infected.

Myhep Dvir Tablet contains antiviral drugs daclatasvir and sofosbuvir reduce the amount of the virus in the body, which is how they treat chronic hepatitis C (HCV). They function by preventing the activity of two proteins that are necessary for the virus to replicate.

Myhep Dvir Tablet should be taken in the dose and duration prescribed by the doctor. In some cases, Myhep Dvir Tablet may cause common side effects such as nausea, diarrhoea, abdominal pain, difficulty sleeping, dizziness, tiredness, headache, insomnia (sleeplessness), and joint or muscle pain. Typically, these side effects do not require medical attention and will subside independently. However, if they persist or become more severe, please consult your doctor.

Please inform your doctor if you are allergic to any of the ingredients in Myhep Dvir Tablet or taking any other medications. Avoid using Myhep Dvir Tablet if you are pregnant or planning to become pregnant and are not using birth control. Both you and your partner should use effective birth control methods during treatment and for 5 weeks after finishing the medication. If you become pregnant during treatment, contact your doctor immediately. Myhep Dvir Tablet is not recommended for use in children below 18 years of age, as its efficacy and safety have not been established in this age group. Also, inform your doctor if you have any pre-existing conditions, such as diabetes, hepatitis B, a history of liver transplant, heart or kidney problems, or HIV (human immunodeficiency virus) infection, before starting Myhep Dvir Tablet.

Myhep Dvir Tablet belongs to a class of drugs called 'antivirals,' primarily used to treat chronic HCV (Hepatitis C virus) infection, particularly genotype 3. It contains antiviral drugs daclatasvir and sofosbuvir, which reduce the amount of the virus in the body, which is how they treat chronic hepatitis C (HCV). They function by preventing the activity of two proteins that are necessary for the virus to replicate.

Please inform your doctor if you are allergic to any ingredients in Myhep Dvir Tablet or if you are taking any other medications, including prescription and over-the-counter (OTC) drugs, vitamins, or herbal supplements. If you are taking Myhep Dvir Tablet along with amiodarone (a medication for irregular heartbeats), you may need regular heart monitoring, as it could excessively slow your heart rate (severe bradycardia). Avoid using Myhep Dvir Tablet if you are pregnant or planning to become pregnant and are not using birth control. Both you and your partner should use effective birth control methods during treatment and for 5 weeks after finishing the medication. If you become pregnant during treatment, contact your doctor immediately. Myhep Dvir Tablet is not recommended for use in children below 18 years of age, as its efficacy and safety have not been established in this age group. If you are infected with hepatitis C, take the necessary precautions to prevent spreading the infection to others. Before starting treatment, you should be tested for current and past hepatitis B (HBV) infections, as HBV reactivation can occur in people with both HCV and HBV, especially if treated for HCV but not HBV. Additionally, inform your doctor if you have any pre-existing conditions, such as diabetes, hepatitis B, a history of liver transplant, heart or kidney problems, or HIV (human immunodeficiency virus) infection, before starting Myhep Dvir Tablet.